Trimetazidine Dihydrochloride TRIMESAPH-35 35mg Modified-Release Film-Coated Tablet 100’s

Trimetazidine Dihydrochloride TRIMESAPH-35 35mg Modified-Release Film-Coated Tablet 100’s

Description:
TRIMESAPH-35 contains Trimetazidine Dihydrochloride 35mg in a modified-release film-coated tablet formulation. It is classified as an antianginal medication used to help improve the heart’s energy metabolism by supporting oxygen utilization in heart cells, particularly in patients experiencing angina (chest pain due to reduced blood flow to the heart).

Uses:
Used as adjunct therapy for stable angina pectoris to help reduce episodes of chest pain and discomfort caused by coronary artery disease. It may help improve exercise tolerance and support heart function when taken as prescribed by a physician.